DE69903315D1 - Pharmazeutische zubereitungen enthaltend hydroxylansoprazol und deren verwendungen - Google Patents

Pharmazeutische zubereitungen enthaltend hydroxylansoprazol und deren verwendungen

Info

Publication number
DE69903315D1
DE69903315D1 DE69903315T DE69903315T DE69903315D1 DE 69903315 D1 DE69903315 D1 DE 69903315D1 DE 69903315 T DE69903315 T DE 69903315T DE 69903315 T DE69903315 T DE 69903315T DE 69903315 D1 DE69903315 D1 DE 69903315D1
Authority
DE
Germany
Prior art keywords
hydroxylansoprazole
hydroxylansoprazol
pharmaceutical preparations
preparations containing
lansoprazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69903315T
Other languages
English (en)
Other versions
DE69903315T2 (de
Inventor
E Yelle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunovion Pharmaceuticals Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of DE69903315D1 publication Critical patent/DE69903315D1/de
Application granted granted Critical
Publication of DE69903315T2 publication Critical patent/DE69903315T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69903315T 1998-07-22 1999-07-19 Pharmazeutische zubereitungen enthaltend hydroxylansoprazol und deren verwendungen Expired - Lifetime DE69903315T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9376298P 1998-07-22 1998-07-22
PCT/US1999/016322 WO2000004904A1 (en) 1998-07-22 1999-07-19 Pharmaceutical compositions comprising hydroxylansoprazole and uses thereof

Publications (2)

Publication Number Publication Date
DE69903315D1 true DE69903315D1 (de) 2002-11-07
DE69903315T2 DE69903315T2 (de) 2003-06-18

Family

ID=22240576

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69903315T Expired - Lifetime DE69903315T2 (de) 1998-07-22 1999-07-19 Pharmazeutische zubereitungen enthaltend hydroxylansoprazol und deren verwendungen

Country Status (9)

Country Link
US (3) US6335351B1 (de)
EP (1) EP1098648B1 (de)
JP (1) JP2002521336A (de)
AT (1) ATE225175T1 (de)
AU (1) AU763642B2 (de)
CA (1) CA2337886C (de)
DE (1) DE69903315T2 (de)
ES (1) ES2182554T3 (de)
WO (1) WO2000004904A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100434904B1 (ko) * 2002-05-30 2004-06-11 주식회사 대웅 안정화된 란소프라졸을 함유하는 장용성 제제

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法

Also Published As

Publication number Publication date
US20040077688A1 (en) 2004-04-22
CA2337886C (en) 2008-04-08
DE69903315T2 (de) 2003-06-18
WO2000004904A1 (en) 2000-02-03
US6335351B1 (en) 2002-01-01
US20020099079A1 (en) 2002-07-25
US7098224B2 (en) 2006-08-29
EP1098648A1 (de) 2001-05-16
EP1098648B1 (de) 2002-10-02
CA2337886A1 (en) 2000-02-03
ES2182554T3 (es) 2003-03-01
AU5218299A (en) 2000-02-14
AU763642B2 (en) 2003-07-31
ATE225175T1 (de) 2002-10-15
JP2002521336A (ja) 2002-07-16

Similar Documents

Publication Publication Date Title
SE0102315D0 (sv) Compounds
ATE101517T1 (de) Pharmazeutische zusammensetzung, enthaltend loratadin, ibuprofen und pseudoephedrin.
DE60228330D1 (de) Kondensierte heterocyclische verbindungen und deren analoga; modulatoren der funktion von nukleären hormonrezeptoren
ATE551363T1 (de) Verwendung von antikörper gegen interleukin-4 rezeptor und deren zusammensetzungen
EE03177B1 (et) Heterobitsüklilised ühendid, nende saamismeetod ja nimetatud ühendeid sisaldavad farmatseutilised kompositsioonid
DE69802260D1 (de) Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen
DK1053256T3 (da) Antistoffer mod Dødsreceptor 4 (DR4) og anvendelser deraf
NO20035498D0 (no) Farmas degree ytiske preparater eller adsorbater av amorft legemiddel
NO983003L (no) Vitronectin-reseptor-antagonister
NO20000265D0 (no) Kontrollert cytolyse av målceller, midler og sammensetninger som forårsaker cytolyse og forbindelser som kan anvendes for å fremstille midlene
NO20051404L (no) Pyridylsubstituerte heterocykluser som er nyttige for behandling eller forebyggelse av HCV infeksjon
DE69818286D1 (de) Pyridylverbindungen und diese enthaltende pharmazeutische zubereitungen
ATE400258T1 (de) Transdermales buprenorphin-dosierschema zwecks schmerzstillung
NO20016232L (no) Amorfe salpetersyre-estere og farmasöytiske preparater inneholdene disse
HUP0103203A2 (hu) Azaadamantánszármazékok és ezeket tartalmazó gyógyszerkészítmények
SE0203825D0 (sv) Novel fused heterocycles and uses thereof
ATE323693T1 (de) Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen
IT1298338B1 (it) Composizioni farmaceutiche per l'ulcera
DE69902657D1 (de) Hydroxyomeprazol-enthaltende zubereitungen und verwendungen
SE0003476D0 (sv) Compounds
SE0004054D0 (sv) N-type calcium channel antagonists for the treatment of pain
EE200100520A (et) N-(2-fenüül-4-aminobutüül)-1-naftamiidid neurokiniin-1-retseptori antagonistidena
DE69903315T2 (de) Pharmazeutische zubereitungen enthaltend hydroxylansoprazol und deren verwendungen
NO20010464D0 (no) Fremgangsmåter og sammensetninger for behandling av gastroösofrageal-reflukssyndrom
DK1075262T3 (da) Desmethylpantoprazolpræparater og -fremgangsmåder

Legal Events

Date Code Title Description
8364 No opposition during term of opposition